AP NEWS

Global Endocrine Testing Market Report (2018-2023): Sedentary Lifestyles is Propelling the Growth of this Market - ResearchAndMarkets.com

December 20, 2018

DUBLIN--(BUSINESS WIRE)--Dec 20, 2018--The “Global Endocrine Testing Market - Forecasts From 2018 to 2023” report has been added to ResearchAndMarkets.com’s offering.

The global endocrine testing market is projected to grow at a CAGR of 6.64%, increasing from US$8.215 billion in 2017 to US$12.080 billion in 2023.

Endocrine testing market is expected to show a robust growth during the given forecast period. Sedentary lifestyles leading to the development of the stress and other related disorders such as diabetes and obesity have given a boost to the market.

Introduction of easy-to-operate test kits which are user-friendly and cost-effective will also drive the market for endocrine testing during the given time frame.

However, high cost of development of the technology for endocrine testing might restrain the market growth for the given forecast period.

Major industry players profiled as part of the report are Hoffmann-La Roche Ltd, Thermo Fisher Scientific, and Abbott among others.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Key Findings of the Study

4. Market Dynamics

5. Global Endocrine Testing Market Forecast by Technology

5.1. Liquid Chromatography-Mass Spectrometry (LC-MS)

5.2. Immunoassay

5.3. ELISA

5.4. Tandem Mass spectrometry

5.5. Others

6. Global Endocrine Testing Market Forecast by Application

6.1. Cortisol Test

6.2. Human Chorionic Gonadotropin (HCG) Test

6.3. Dehydroepiandrosterone Sulfate (DHEAS) Test

6.4. Thyroid Stimulating Hormone (TSH) Test

6.5. Prolactin Test

6.6. Insulin

6.7. Others

7. Global Endocrine Testing Market Forecast by End Users

7.1. Hospitals and Clinics

7.2. Diagnostic Centres

8. Global Endocrine Testing Market Forecast by Geography (US$ billion)

8.1. North America

8.2. South America

8.3. Europe

8.4. Middle East and Africa

8.5. Asia Pacific

9. Competitive intelligence

9.1. Market Share Analysis

9.2. Strategies of Key Players

9.3. Recent Investments and Deals

10. Company Profiles

10.1. Randox Laboratories Ltd.

10.2. Abbott

10.3. Agilent Technologies

10.4. bioMerieux S.A.

10.5. Bio Rad Laboratories

10.6. Hoffmann-La Roche Ltd

10.7. Beckman Coulter Inc.

10.8. Siemens Healthineers

10.9. Thermo Fisher Scientific

10.10. AB Sciex

For more information about this report visit https://www.researchandmarkets.com/research/4c4r87/global_endocrine?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181220005851/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Endocrinology

KEYWORD:

INDUSTRY KEYWORD: HEALTH DIABETES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/20/2018 03:34 PM/DISC: 12/20/2018 03:33 PM

http://www.businesswire.com/news/home/20181220005851/en

AP RADIO
Update hourly